Blog

High-intensity training is better than conventional training for locomotion, cognition, and aerobic capacity in moderate-to-severe TBI

The Journal of Neurotrauma recently published a study comparing conventional rehabilitation to high-intensity training (HIT) in patients with moderate-to-severe traumatic brain injury. Compared to rehabilitation, high-intensity training participants showed better outcomes in the physical tests used to measure locomotive outcomes (6-min walk test and peak treadmill speed). There were also more improvements in aerobic capacity and cognitive functioning after HIT. 

Read More
cannabis and psychedelics Conor Gormally cannabis and psychedelics Conor Gormally

“Atypical psychedelic” ibogaine shows promise as a treatment for chronic disability following TBI

A landmark study published in Nature Medicine found that ibogaine, an “atypical psychedelic” derived from the root bark of an African shrub, showed highly beneficial effects on emotional well-being and cognition in a group of Special Operations Forces (SOF) veterans with chronic illness relating to their military careers and history of traumatic brain injury (TBI), primarily mild TBIs.

Read More
mental health Esmeralda Garcia-Ramirez mental health Esmeralda Garcia-Ramirez

Athletes with comorbid depression and anxiety and no recent concussion  report more post-concussion symptoms than “healthy mood” athletes who are two weeks post-concussion

Scientists have found that athletes with baseline comorbid depression and anxiety reported more symptoms on the Post-Concussion Symptom Scale, without having a recent concussion, than the post-concussion athletes who had a healthy mood at baseline.

Read More
CTE & Neurodegeneration Issues Lillian Lee CTE & Neurodegeneration Issues Lillian Lee

Blood biomarkers detect reduced brain structure volume associated with repetitive head impacts in professional boxers and MMA fighters

A study in Neurology Advisor found that for active and retired professional fighters exposed to repetitive head impacts, blood plasma measurements of the biomarkers GFAP and NfL “may help identify those who are at risk for progressive regional brain atrophy and cognitive decline.”

Read More